Business Description
Valbiotis SA
ISIN : FR0013254851
Compare
Compare
Traded in other countries / regions
ALVAL.France8JD.Germany IPO Date
2017-06-07Description
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.64 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -1.08 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.67 | |||||
Beneish M-Score | 1.88 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.9 | |||||
3-Year EBITDA Growth Rate | -17.4 | |||||
3-Year EPS without NRI Growth Rate | -4.6 | |||||
3-Year Book Growth Rate | 10.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.99 | |||||
9-Day RSI | 28.51 | |||||
14-Day RSI | 24.86 | |||||
6-1 Month Momentum % | -22.2 | |||||
12-1 Month Momentum % | -9.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.49 | |||||
Quick Ratio | 3.38 | |||||
Cash Ratio | 2.85 | |||||
Days Inventory | 140.76 | |||||
Days Sales Outstanding | 122.75 | |||||
Days Payable | 290.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.1 | |||||
Shareholder Yield % | 2.16 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.37 | |||||
Operating Margin % | -151.66 | |||||
Net Margin % | -155.67 | |||||
FCF Margin % | -175.77 | |||||
ROE % | -49.52 | |||||
ROA % | -25.86 | |||||
ROIC % | -75.62 | |||||
ROC (Joel Greenblatt) % | -309.17 | |||||
ROCE % | -35.17 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.94 | |||||
PB Ratio | 0.88 | |||||
Price-to-Tangible-Book | 1.03 | |||||
EV-to-EBIT | -0.12 | |||||
EV-to-EBITDA | -0.13 | |||||
EV-to-Revenue | 0.18 | |||||
EV-to-FCF | 0.11 | |||||
Price-to-Net-Current-Asset-Value | 1.13 | |||||
Price-to-Net-Cash | 1.67 | |||||
Earnings Yield (Greenblatt) % | -814.95 | |||||
FCF Yield % | -43.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valbiotis SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4.733 | ||
EPS (TTM) (€) | -0.59 | ||
Beta | -0.72 | ||
Volatility % | 84.57 | ||
14-Day RSI | 24.86 | ||
14-Day ATR (€) | 0.215465 | ||
20-Day SMA (€) | 1.5017 | ||
12-1 Month Momentum % | -9.74 | ||
52-Week Range (€) | 1.07 - 7.5 | ||
Shares Outstanding (Mil) | 15.78 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Valbiotis SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Valbiotis SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Valbiotis SA Frequently Asked Questions
What is Valbiotis SA(XPAR:ALVAL)'s stock price today?
The current price of XPAR:ALVAL is €1.20. The 52 week high of XPAR:ALVAL is €7.50 and 52 week low is €1.07.
When is next earnings date of Valbiotis SA(XPAR:ALVAL)?
The next earnings date of Valbiotis SA(XPAR:ALVAL) is .
Does Valbiotis SA(XPAR:ALVAL) pay dividends? If so, how much?
Valbiotis SA(XPAR:ALVAL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |